Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in Ivory Coast has been increasing steadily in recent years, driven by various factors such as rising awareness about the importance of vaccination, increasing government initiatives to improve healthcare infrastructure, and a growing population.
Customer preferences: Ivory Coast has a young and growing population, which is increasingly aware of the importance of vaccination. The country has made significant progress in expanding its healthcare infrastructure, which has helped to increase access to vaccines for the population. Additionally, the government has been actively promoting vaccination campaigns to raise awareness about the importance of immunization.
Trends in the market: The vaccines market in Ivory Coast is expected to continue to grow in the coming years, driven by increasing demand for vaccines and a growing population. The government's initiatives to improve healthcare infrastructure and promote vaccination campaigns are also expected to contribute to the growth of the market. The demand for vaccines is expected to be particularly strong for diseases such as measles, polio, and yellow fever.
Local special circumstances: Ivory Coast is a developing country with a growing population, which presents both opportunities and challenges for the vaccines market. While the increasing population provides a large potential market for vaccines, the country's limited healthcare infrastructure and resources pose a challenge to the distribution and administration of vaccines. Additionally, the country has experienced political instability in the past, which has affected the healthcare system and could impact the vaccines market.
Underlying macroeconomic factors: The Ivory Coast economy has been growing steadily in recent years, driven by a combination of factors such as increasing investment, expanding infrastructure, and a growing population. However, the country still faces significant challenges such as poverty, inequality, and limited resources. These factors could impact the demand for vaccines, as well as the ability of the healthcare system to distribute and administer vaccines effectively. Additionally, the country's reliance on agriculture and commodity exports makes it vulnerable to fluctuations in global commodity prices, which could impact the overall economy and the healthcare system.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
